Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
12.75
-0.08 (-0.62%)
At close: Oct 30, 2026, 4:00 PM EDT
12.50
-0.25 (-1.96%)
After-hours: Oct 30, 2026, 7:30 PM EDT

IART Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
13.01-516.47-6.9467.74180.55169.08
Depreciation & Amortization
154.06151.83140.89123.51118.3119.84
Other Amortization
4.15.615.596.166.857.03
Loss (Gain) From Sale of Assets
2.210.491.50.78-7.46-39.56
Asset Writedown & Restructuring Costs
-511.3712.21--2.75
Stock-Based Compensation
19.7518.5824.3820.1427.7336.21
Other Operating Activities
-17.82-87.28-17.243.19-22.07-1.08
Change in Accounts Receivable
12.12-0.497.44.59-33.917.27
Change in Inventory
16.94-46.76-28.15-59.77-29.125.37
Change in Accounts Payable
-15.5126.72-2.67-20.2317.3432.87
Change in Unearned Revenue
-0.943.43.540.134.270.03
Change in Other Net Operating Assets
-47.52-16.62-11.12-6.291.99-27.38
Operating Cash Flow
140.450.38129.38139.96264.47312.43
Operating Cash Flow Growth
57.21%-61.06%-7.56%-47.08%-15.35%53.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-54.62-81.44-104.42-66.87-42.34-48.02
Sale of Property, Plant & Equipment
----11.150
Cash Acquisitions
---277.81--51.51-303.91
Divestitures
----23.96190.47
Sale (Purchase) of Intangibles
-14.2-14.2-9.95--4.74-0.06
Investment in Securities
-23.98-1.55.5-32.69--
Other Investing Activities
-10.49-10.92-4.135.384.910.08
Investing Cash Flow
-103.28-108.06-390.81-94.18-58.58-161.44

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-720.7486.5165.140.7525.5
Long-Term Debt Repaid
--669.89-187.13-110.6-148.55-125.5
Net Debt Issued (Repaid)
-6.0550.81299.3754.5-107.8-100
Issuance of Common Stock
0.760.966.44.325.476.82
Repurchase of Common Stock
-1.93-2.92-55.98-280.86-149.62-4.8
Other Financing Activities
-7.25-20.52-11.92-7.88--0.25
Financing Cash Flow
-14.4728.34237.86-229.93-251.95-98.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.5718.02-6.463.89-10.72-9.48
Net Cash Flow
20.08-11.33-30.03-180.26-56.7943.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
85.78-31.0524.9673.09222.13264.41
Free Cash Flow Growth
---65.84%-67.09%-15.99%60.30%
Free Cash Flow Margin
5.18%-1.90%1.55%4.74%14.26%17.14%
Free Cash Flow Per Share
1.10-0.410.320.912.663.09
Levered Free Cash Flow
106.2844.4690.1584.87165.64377.4
Unlevered Free Cash Flow
159.7492.77128.7110.82189.79401.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
81.481.464.444.342.243.2
Cash Income Tax Paid
17.217.222.723.635.949.5
Change in Working Capital
-34.91-33.74-31.01-81.57-39.4218.16
SEC Filings: 10-K · 10-Q